Vimarsana
Biggest News Aggregation in the World

Matt Sause News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matt Sause. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matt Sause Today - Breaking & Trending Today

Roche granted FDA Breakthrough Device Designation - Vimarsana News

Roche granted FDA Breakthrough Device Designation

Roche announces that the Tina-quant lipoprotein Lp(a) RxDx assay receives Breakthrough Device Designation from the FDA

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk - Vimarsana News

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics...

F. Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics Tina-quant®

FDA Approves Self-Collection cobas HPV Test for Early Detection of Cervical Cancer Early - Vimarsana News

FDA Approves Self-Collection cobas HPV Test for Early Detection of Cervical Cancer Early

In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.

Roche gains FDA approval of HPV self-collection solution - Vimarsana News

Roche gains FDA approval of HPV self-collection solution

Expanding access and screening options to help eliminate cervical cancer